GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » Total Equity

Fortrea Holdings (FRA:K67) Total Equity : €1,465 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings Total Equity?

Fortrea Holdings's total equity for the quarter that ended in Mar. 2024 was €1,465 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Fortrea Holdings Total Equity Historical Data

The historical data trend for Fortrea Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings Total Equity Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Equity
- 2,885.63 3,155.41 1,594.48

Fortrea Holdings Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1,686.34 1,616.27 1,587.56 1,594.48 1,464.55

Fortrea Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Fortrea Holdings's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=3995.552-2401.073
=1,594

Fortrea Holdings's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=3900.984-2436.436
=1,465

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fortrea Holdings Total Equity Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Fortrea Holdings (FRA:K67) Business Description

Traded in Other Exchanges
Address
8 Moore Drive, Durham, NC, USA, 27709
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines